跳轉至內容
Merck

P1793

匹莫齐特

≥98% (TLC), powder, D₂ dopamine receptor antagonist

同義詞:

1-[1-[4,4-双(4-氟苯基)丁基]-4-哌啶基]-1,3-二氢-2H-苯并咪唑-2-酮

登入 檢視組織與合約價格。

選擇尺寸

暫時無法取得訂價和供貨情況

關於此項目

經驗公式(希爾表示法):
C28H29F2N3O
CAS 編號:
分子量::
461.55
EC號碼:
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

跳轉至

技術服務
需要援助?我們經驗豐富的科學家團隊隨時樂意為您提供支援。
讓我們為您提供幫助

產品名稱

匹莫齐特,

形狀

powder

品質等級

溶解度

DMSO: 18 mg/mL(lit.)
chloroform: 5 mg/mL
H2O: insoluble(lit.)

起源

Teva

儲存溫度

2-8°C

SMILES 字串

Fc1ccc(cc1)C(CCCN2CCC(CC2)N3C(=O)Nc4ccccc34)c5ccc(F)cc5

InChI

1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)

InChI 密鑰

YVUQSNJEYSNKRX-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

比較類似項目

查看完整比較

Show Differences

1 of 4

本產品
P1750000BP682P-168
匹莫齐特 British Pharmacopoeia (BP) Reference Standard

BP682

匹莫齐特

form

powder

form

-

form

solid

form

-

Quality Level

200

Quality Level

-

Quality Level

-

Quality Level

300

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

-10 to -25°C

solubility

DMSO: 18 mg/mL(lit.), H2O: insoluble(lit.), chloroform: 5 mg/mL

solubility

-

solubility

-

solubility

-

originator

Teva

originator

-

originator

-

originator

-

Gene Information

human ... ABCB1(5243), CACNA1G(8913), CYP3A4(1576), DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816), HTR2A(3356), HTR7(3363), KCNH1(3756), KCNH2(3757), OPRD1(4985)
mouse ... Abcb1a(18671), Abcb1b(18669)
rat ... Scnn1g(24768)

Gene Information

human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816), HTR2A(3356)

Gene Information

human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816), HTR2A(3356)

Gene Information

-

生化/生理作用

D 2 多巴胺受体拮抗剂;与克隆的 5-HT 7 受体高亲和力结合;Ca 2 + 通道拮抗剂;抗精神病药

特點和優勢

该化合物在受体分类和信号转导手册的环核苷酸门控(CNG)和超极化激活的环核苷酸门控(HCN)通道页面上有详细描述。想要浏览手册的其他页面, 请单击此处
该化合物是环核苷酸研究的特色产品。 点击此处 ,发现更多特色环核苷酸产品。。在 sigma.com/discover-bsm了解更多关于其他研究领域的生物活性小分子。
该化合物由 Teva 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Junjun Chen et al.
Chemistry & biology, 18(11), 1390-1400 (2011-11-29)
Ubiquitin-specific proteases (USPs) have in recent years emerged as a promising therapeutic target class. We identified selective small-molecule inhibitors against a deubiquitinase complex, the human USP1/UAF1, through quantitative high throughput screening (qHTS) of a collection of bioactive molecules. The top
Holger H H Erb et al.
PloS one, 15(8), e0237248-e0237248 (2020-08-14)
Despite enzalutamide's efficacy in delaying the progression of metastatic castration-resistant prostate cancer (CRPC), resistance to this anti-androgen inevitably occurs. Several studies have revealed that the signal transducer and activator of transcription (STAT) 5 plays a role in tumour progression and
The Role of a Natural Amphibian Skin-Based Peptide, Ranatensin, in Pancreatic Cancers Expressing Dopamine D2 Receptors.
Laskowska, et al.
Cancers, 14 (2022)
Tamara Pringsheim et al.
The Cochrane database of systematic reviews, (2)(2), CD006996-CD006996 (2009-04-17)
Neuroleptic drugs with potent D-2 receptor blocking properties have been the traditional treatment for tics caused by Tourette Syndrome. Pimozide is the most studied of these. Use of these medications is declining because of concerns about side effects, and new
Wilhelmus J J M Martin et al.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 111(5), 627-633 (2011-04-19)
Controversy exists about the effectiveness of anticonvulsants for the management of orofacial pain disorders. To ascertain appropriate therapies, a systematic review was conducted of existing randomized controlled trials. Trials were identified from PubMed, Cochrane, and Ovid Medline databases from 1962

文章

Cyclic nucleotides like cAMP modulate cell function via PKA activation and ion channels.

Questions

  1. When dissolved in DMSO, at what temperature should I store the solution?

    1 answer
    1. The storage temperature and solution stability after reconstitution in DMSO have not been tested. It is recommended to make the solution fresh upon usage.

      Helpful?

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務